This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Celyntra Therapeutics Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Genome Editing by Rongming Liu
Introduction
Rongming Liu is an accomplished inventor based in Boulder, CO (US). He has made significant contributions to the field of genome editing, focusing on efficient and specific methods for modifying genetic material. His work has the potential to impact various biological and medical applications.
Latest Patents
Rongming Liu holds a patent titled "Constructs and uses thereof for efficient and specific genome editing." This patent includes embodiments that disclose novel nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems. The methods described in the patent can be utilized for editing the genomes of humans and other species. Notably, the patent outlines techniques such as recursive genetic engineering and trackable genetic engineering methods.
Career Highlights
Rongming Liu is currently associated with Celyntra Therapeutics, where he applies his expertise in genome editing. His innovative approaches have garnered attention in the scientific community, contributing to advancements in genetic research and therapeutic applications.
Collaborations
Rongming Liu collaborates with talented individuals such as Jamie Kershner and Liya Liang. Their combined efforts enhance the research and development initiatives at Celyntra Therapeutics.
Conclusion
Rongming Liu's work in genome editing exemplifies the intersection of innovation and science. His contributions are paving the way for future advancements in genetic engineering and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile